Richard T. LeBuhn, Director at Asterias Biotherapeutics, Inc. (AST), bought 15,000 shares at $3.39 ($51K) on 2016-05-13, disclosed to the SEC on 2016-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CMRO | BUY | 2013-02-22 | $10K | — | Filing → |